Michael X. Repka

Does Past Myopia Progression Predict Future Progression?

Special Commentary: Reporting Clinical Endpoints in Studies of Minimally Invasive Glaucoma Surgery

P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity

Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age

Complications, Visual Acuity, and Refractive Error 3 Years after Secondary Intraocular Lens Implantation for Pediatric Aphakia

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

IMI—Management and Investigation of High Myopia in Infants and Young Children

Incidence of Glaucoma-Related Adverse Events in the First 5 Years After Pediatric Lensectomy

Eight-Year Outcomes of Bilateral Lateral Rectus Recessions versus Unilateral Recession-Resection in Childhood Basic-Type Intermittent Exotropia

Complications Occurring Through 5 Years Following Primary Intraocular Lens Implantation for Pediatric Cataract

Pediatric Eye Evaluations Preferred Practice Pattern

Artificial Intelligence for Retinopathy of Prematurity

Association of Strabismus With Mood Disorders, Schizophrenia, and Anxiety Disorders Among Children

Esotropia and Exotropia Preferred Practice Pattern®

Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 Years

Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity

The Pediatric Optic Neuritis Prospective Outcomes Study

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants

Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia

A prospective study of treatments for adult-onset divergence insufficiency–type esotropia

Reducing the Global Burden of Myopia by Delaying the Onset of Myopia and Reducing Myopic Progression in Children

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity

Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria

Amblyopia Preferred Practice Pattern®

Pediatric Eye Evaluations Preferred Practice Pattern®

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity

PEDIG Lensectomy Registry: Rates of Amblyopia Treatment, Glaucoma and Other Complications One Year after Surgery

Expert Diagnosis of Plus Disease in Retinopathy of Prematurity From Computer-Based Image Analysis

Plus Disease in Retinopathy of Prematurity

Plus Disease in Retinopathy of Prematurity